When to Intervene—Should Surgical Guidelines Apply to Transcatheter Techniques in Treating Mitral Regurgitation?

Le résumé fourni par la source

In clinical practice, guidelines attempt to summarize the status quo of the best available evidence for managing patients with a given disease. Given the rapid expansion of transcatheter mitral valve interventions in inoperable or high-surgical-risk individuals, considerable interest lies in how one should contextualize the emerging transcatheter technologies within the framework of clinical guidelines. Surgery remains the gold-standard approach for treating severe primary mitral regurgitation (MR). However, the dramatic and ongoing evolution of transcatheter mitral valve therapies, coupled with significant long-standing (largely European) experience with the edge-to-edge MitraClip system for both primary and secondary severe MR, has allowed a percutaneous approach to find its place in the treatment armamentarium of high-risk MR patients. Further trials are needed to evaluate the efficacy of transcatheter treatment approaches for severe MR, as well as the use of small footprint devices on lower-surgical-risk patients with secondary MR of moderate severity.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.